These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5529891)

  • 21. [The influence of thyroid gland function on the pharmacological action of propranolol, adrenaline, noradrenaline and dinitrophenol].
    Strubelt O
    Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):263-88. PubMed ID: 5715404
    [No Abstract]   [Full Text] [Related]  

  • 22. Desipramine toxicity and its treatment.
    Laddu AR; Somani P
    Toxicol Appl Pharmacol; 1969 Sep; 15(2):287-94. PubMed ID: 5804746
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of epinephrine and ouabain on automaticity of canine Purkinje fibers.
    Tse WW; Han J
    Circ Res; 1974 Jun; 34(6):777-82. PubMed ID: 4832703
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of epinephrine, norepinephrine and some blocking agents on tunicate smooth muscle.
    Akers TK
    Comp Biochem Physiol; 1969 May; 29(2):813-9. PubMed ID: 5788615
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of propranolol on the pressor response to acetylcholine in atropinized dogs.
    Abiko Y; Ito G
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):413-9. PubMed ID: 6058777
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.
    Akera T; Larsen FS; Brody TM
    J Pharmacol Exp Ther; 1970 May; 173(1):145-51. PubMed ID: 4245610
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective augmentation of the pressor responses to catecholamines by metanephrine.
    Allen DO; Calvert DN; Lum BK
    J Pharmacol Exp Ther; 1969 Jun; 167(2):309-18. PubMed ID: 4306903
    [No Abstract]   [Full Text] [Related]  

  • 28. Release of catecholamines during the induction of and recovery from tachyphylaxis to angiotensin II.
    Cline WH
    J Pharmacol Exp Ther; 1971 Dec; 179(3):532-42. PubMed ID: 4332750
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology.
    Kasuya Y; Watanabe M
    Arzneimittelforschung; 1965 Nov; 15(11):1279-84. PubMed ID: 4382189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 32. [Supramaximal effect of epinephrine on guinea pig papillary muscle under the influence of phenethylamine derivatives].
    Brandt W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):301-2. PubMed ID: 4253743
    [No Abstract]   [Full Text] [Related]  

  • 33. The positive inotropic action of insulin in the canine heart.
    Lucchesi BR; Medina M; Kniffen FJ
    Eur J Pharmacol; 1972 Apr; 18(1):107-15. PubMed ID: 5031268
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of cardiac glycosides and aglycones on the sufficient heart].
    Bussmann WD; Wirz P; Lüthy E; Krayenbühl HP
    Dtsch Med Wochenschr; 1969 Apr; 94(15):779-85. PubMed ID: 5777261
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of adrenergic stimulant and blocking drugs on the release and uptake of potassium by the liver.
    Castro-Travares J; Cardoso W
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):100-12. PubMed ID: 4413113
    [No Abstract]   [Full Text] [Related]  

  • 36. An evaluation of the inability of cocaine to potentiate the responses to cardiac sympathetic nerve stimulation in the dog.
    Koerker RL; Moran NC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):482-96. PubMed ID: 5571899
    [No Abstract]   [Full Text] [Related]  

  • 37. Adrenergic contribution to digitalis action.
    Tanabe T; Shudo I; Saito H
    Proc West Pharmacol Soc; 1975; 18():20-2. PubMed ID: 241087
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of fatty acids on pressor responses to catecholamines.
    Chopde CT; Brahmankar DM; Jadhav SS; Hardas AP; Dorle AK
    Indian J Physiol Pharmacol; 1975; 19(3):146-51. PubMed ID: 173652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental studies on the effects of propranolol and phenozybenzamine on the electrocardiogram and coronary blood flow.
    Hayase S; Ito H; Kondo Y; Imao T
    Isr J Med Sci; 1969; 5(4):515-8. PubMed ID: 5820468
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.